Ischemic stroke and patent foramen ovale: risk factors and genetic profile

Maria Lantz1, Christina Sjöstrand, Konstantinos Kostulas

  • 1Department of Neurology, Karolinska Institutet, Karolinska University Hospital Huddinge, Sweden. maria.lantz@karolinska.se

Insights

Patent foramen ovale (PFO) is linked to ischemic cerebrovascular disease (ICVD). Genetic analysis revealed a strong association between the F2 gene polymorphism and both PFO and ICVD in stroke patients.

Area of Science:

  • Cardiovascular Genetics
  • Neurology
  • Stroke Research

Background:

  • Patent foramen ovale (PFO) is a potential risk factor for ischemic cerebrovascular disease (ICVD), particularly in younger individuals.
  • The precise role of PFO in the pathophysiology of ischemic stroke remains debated and requires further investigation.
  • This study explored conventional risk factors and genetic polymorphisms associated with ICVD in patients with and without PFO.

Purpose of the Study:

  • To investigate the association between genetic polymorphisms and ischemic cerebrovascular disease (ICVD) in patients with and without patent foramen ovale (PFO).
  • To identify specific gene variants that may confer susceptibility to ICVD in the presence of PFO.

Main Methods:

  • Genotyping of 100 polymorphisms in 47 suspected susceptibility genes was performed on 928 ICVD patients and 602 controls from the South Stockholm Ischemic Stroke Study.
  • Stroke patients underwent comprehensive investigations, including standardized blood tests and, for a subset, transesophageal echocardiography to determine PFO status.
  • Patients were categorized into groups based on the presence or absence of PFO.

Main Results:

  • No significant differences in conventional risk factors or blood test results were observed between patients with and without PFO.
  • Three polymorphisms in the prothrombin (F2) gene (20210G/A) and apolipoprotein-C3 (APO-CIII) genes (-641A/C and -455T/A) showed a significant association with ICVD and PFO.
  • The F2 gene polymorphism exhibited the strongest association (P = .0049; odds ratio 26.4).

Conclusions:

  • The prothrombin F2 gene polymorphism is significantly associated with both ICVD and PFO, supporting its potential role as a link between these conditions.
  • A trend towards association was observed between two APO-CIII gene polymorphisms and the co-occurrence of PFO and ICVD.
  • These genetic findings contribute to understanding the complex relationship between PFO and stroke risk.
Abstract

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...